Interaction Check

This page cannot be displayed because your browser has been configured to disable JavaScript, also known as "Active Scripting".Please change your settings and refresh the page.

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

MultiCheck Results - 10 Interactions

Avoid/Use Alternative
Myzilra (levonorgestrel/ ethinyl estradiol) + Syeda (drospirenone/ ethinyl estradiol)
Avoid/Use Alternative ethinyl estradiol (contraceptive) + ethinyl estradiol (contraceptive) avoid combo: combo may incr. risk of HTN, thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy) levonorgestrel (contraceptive) + drospirenone (contraceptive) avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy)
Monitor/Modify Tx
Jentadueto XR (linagliptin/ metformin) + Myzilra (levonorgestrel/ ethinyl estradiol)
Monitor/Modify Tx linagliptin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) linagliptin + levonorgestrel (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) metformin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) metformin + levonorgestrel (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)
Jentadueto XR (linagliptin/ metformin) + Syeda (drospirenone/ ethinyl estradiol)
Monitor/Modify Tx linagliptin + drospirenone (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) linagliptin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) metformin + drospirenone (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) metformin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)